⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VKTX News
Viking Therapeutics, Inc
Form 8-K
sec.gov
VKTX
Viking Therapeutics to Participate at Upcoming Investor Conferences
prnewswire.com
VKTX
Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
globenewswire.com
MRK
ABBV
VKTX
ALT
Viking Therapeutics Presents Data from its 13-Week Phase 2 VENTURE-Oral Dosing Trial of VK2735 at European Congress on Obesity (ECO) 2026
prnewswire.com
VKTX
Sadness This Mother's Day? VITAS® Healthcare Launches Free, Nationwide Mother's Day Grief Helpline
prnewswire.com
CHE
VKTX
Viking Therapeutics Announces Two Poster Presentations at European Congress on Obesity (ECO) 2026
prnewswire.com
VKTX
Form 8-K
sec.gov
LGNZZ
LGND
LGNYZ
LGNXZ
LGNDZ
VKTX
Form 8-K
sec.gov
VKTX
Viking Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
prnewswire.com
VKTX
The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial
globenewswire.com
LLY
NVO
VKTX
LGVN